Abstract
AbstractAsherman’s Syndrome is characterized by intrauterine adhesions or scarring, which cause infertility, menstrual abnormalities, and recurrent pregnancy loss. The pathophysiology of this syndrome remains unknown, with treatment restricted to recurrent surgical removal of intrauterine scarring, which has limited success. Here, we decode the Asherman’s Syndrome endometrial cell niche by analyzing data from over 200,000 cells with single-cell RNA-sequencing in patients with this condition and through in vitro analyses of Asherman’s Syndrome patient-derived endometrial organoids. Our endometrial atlas highlights the loss of the endometrial epithelium, alterations to epithelial differentiation signaling pathways such as Wnt and Notch, and the appearance of characteristic epithelium expressing secretory leukocyte protease inhibitor during the window of implantation. We describe syndrome-associated alterations in cell-to-cell communication and gene expression profiles that support a dysfunctional pro-fibrotic, pro-inflammatory, and anti-angiogenic environment.
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry,Multidisciplinary
Reference53 articles.
1. Dmowski, W. P. & Greenblatt, R. B. Asherman’s syndrome and risk of placenta accreta. Obstet. Gynecol. 34, 288–299 (1969).
2. Public summary of opinion on orphan designation. Committee Orphan Medicinal Products (COMP). EMA/206895/2017 (2017).
3. Conforti, A., Alviggi, C., Mollo, A., Placido, G. D. & Magos, A. The management of Asherman syndrome: a review of literature. Reprod. Biol. Endocrinol. 11, 118 (2013).
4. Wallach, E. E., Schenker, J. G. & Margalioth, E. J. Intrauterine adhesions: an updated appraisal. Fertil. Steril. 37, 593–610 (1982).
5. Yu, D., Wong, Y.-M., Cheong, Y., Xia, E. & Li, T.-C. Asherman syndrome—one century later. Fertil. Steril. 89, 759–779 (2008).
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献